Does semaglutide suppress appetite from the first dose?

What did @kirstyrebeccasjourney actually say?

Honestly, the transcript we have from this video is garbled audio, likely a song playing over the footage rather than clear speech. The actual content comes from the caption, where the creator writes that they started on 0.5mg yesterday and felt "no appetite suppression at all, still quite hungry." They also mention wanting to hit 10,000 steps daily, return to the gym, and prep meals.

So we are working with written claims rather than spoken ones here. That is worth flagging upfront. The creator is documenting day one of what appears to be a semaglutide injection, using the Ozempic hashtag but also tagging Mounjaro and "semiglutide" (a common misspelling of semaglutide). It is unclear which medication they are actually taking. That ambiguity matters clinically.

What they describe, feeling hungry and noticing zero appetite change on the first day, is a real experience that thousands of people report. The question is whether that experience reflects how the drug actually works, or whether expectations were simply off from the start.

Does the science back this up?

Yes, largely. It would be unusual to feel meaningful appetite suppression 24 hours after a first dose of semaglutide, and the research supports that. The creator is not imagining things or doing something wrong. The drug takes time.

Semaglutide works by mimicking GLP-1, a gut hormone that slows gastric emptying and signals satiety to the brain. But plasma levels after a subcutaneous injection do not peak immediately. According to the prescribing data for Ozempic, peak plasma concentration after a subcutaneous dose is reached at roughly 24 to 72 hours post-injection, and meaningful receptor engagement builds over repeated weekly doses. The SUSTAIN trial series (Marso et al., 2016, New England Journal of Medicine) established efficacy over 30 to 56 weeks, not 30 hours.

Wilding et al. (2021, NEJM), the STEP 1 trial for weight management with semaglutide 2.4mg, showed average body weight reduction of 14.9% over 68 weeks. Nobody in that trial lost weight on day one. The appetite suppression that drives those results builds gradually as the drug accumulates and dose is titrated upward.

What did they get wrong (or right)?

They got the timeline frustration right, but their framing hints at a misunderstanding of how the drug works. Writing "don't know if this is to do with delay in jab" suggests they may have expected fairly immediate effects. That expectation is common and understandable, largely because GLP-1 content online tends to feature dramatic before-and-after stories rather than mechanistic explanations.

What they got right: recognising that diet and physical activity still matter. The instinct to meal prep and increase daily steps is not just sensible lifestyle advice, it is consistent with how clinical trials are designed. The STEP trials included a calorie-reduced diet and increased activity as standard components. Semaglutide is not a standalone fix.

The hashtag confusion between Ozempic and Mounjaro is worth noting. These are different drugs: semaglutide and tirzepatide respectively. Tirzepatide (Mounjaro) is a dual GIP/GLP-1 agonist with a distinct mechanism and different titration schedule. Mixing up hashtags is probably just social media tagging habits, but for anyone reading this as a peer recommendation, the difference matters.

What should you actually know?

If you are starting a GLP-1 receptor agonist and feel nothing on day one, that is expected. The therapeutic effect of semaglutide is not instantaneous. Most clinical guidance involves a titration period of several weeks precisely because the drug needs to build up and your body needs time to adjust.

There is also decent evidence that lifestyle changes the creator mentions, steps and meal prep, work synergistically with GLP-1 treatment. A 2022 analysis by Rubino et al. (NEJM) showed that participants who combined semaglutide with intensive behavioural intervention maintained greater weight loss than drug alone. That is not a minor footnote.

One thing worth saying plainly: if you are sourcing information about dosing or expectations from TikTok captions, you are working with anecdote, not protocol. Day-one hunger does not mean the medication is not working. It means it is day one. Give it weeks, not hours.

• 0.5mg is a common starting dose for semaglutide titration, not a therapeutic ceiling.
• Appetite effects typically become noticeable after multiple doses and dose increases.
• Meal prepping and increasing activity are clinically supported strategies alongside GLP-1 treatment.
• Ozempic and Mounjaro are different drugs with different mechanisms. Do not conflate them based on hashtags.